Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,445,098
+$2,706,154 QoQ
Shares Held
309,979
+66.1% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Jun 30, 2026
CallValue
$2,252,814
CallShares
157,100
PutValue
$156,306
PutShares
10,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. ZVRA ranks #55 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in ZVRA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,445,098 309,979
2026-06-30 $156,306 10,900
2026-06-30 $2,252,814 157,100
2026-03-31 $4,220,096 452,800
2026-03-31 $609,528 65,400
2026-03-31 $1,738,944 186,582
2025-12-31 $223,104 24,900
2025-12-31 $2,626,131 293,095
2025-12-31 $1,766,912 197,200
2025-09-30 $977,628 102,800
2025-09-30 $11,464,438 1,205,514
2025-09-30 $1,648,083 173,300
2025-06-30 $1,422,753 161,493
2025-06-30 $1,273,045 144,500
2025-06-30 $4,203,251 477,100
2025-03-31 $396,221 52,900
2025-03-31 $2,241,757 299,300
2025-03-31 $1,238,958 165,415
2024-12-31 $872,614 104,630
2024-12-31 $768,948 92,200
2024-09-30 $469,838 67,700
2024-09-30 $1,377,590 198,500
2024-09-30 $1,490,698 214,798
2024-06-30 $101,430 20,700
2024-06-30 $678,669 138,504
2024-06-30 $59,290 12,100
2024-03-31 $227,940 39,300
2024-03-31 $151,960 26,200
2024-03-31 $513,932 88,609
2023-12-31 $121,830 18,600
2023-12-31 $752,346 114,862
2023-12-31 $402,170 61,400
2023-09-30 $364,392 75,600
2023-09-30 $214,031 44,405
2023-09-30 $225,576 46,800
2023-06-30 $213,108 41,786
2023-06-30 $599,250 117,500
2023-06-30 $791,520 155,200
2023-03-31 $557,700 101,400
2023-03-31 $590,700 107,400
2023-03-31 $1,106,446 201,172
2022-12-31 $1,018,980 222,000
2022-12-31 $680,238 148,200
2022-12-31 $780,364 170,014
2022-09-30 $903,208 144,745
2022-09-30 $1,335,360 214,000
2022-09-30 $1,801,488 288,700
2022-06-30 $1,338,892 300,200
2022-06-30 $730,998 163,901
2022-06-30 $867,916 194,600